Home » Health and medicine » SynBioBeta State of the Industry Town Hall with Drew Endy

SynBioBeta State of the Industry Town Hall with Drew Endy

Drew Endy is a member of the bioengineering faculty at Stanford University and BioBricks Foundation president (biobricks.org). His research teams pioneered amplifying genetic logic, rewritable DNA data storage, reliably-reuseable standard biological parts, and genome refactoring. Drew helped launch the new undergraduate majors in bioengineering at both MIT and Stanford; he also co-founded the iGEM competition, a global genetic engineering “olympics” now engaging over 6,000 students annually (igem.org). Drew will join SynBioBeta founder John Cumbers for a conversation about the state of the synthetic biology industry. In light of COVID-19, we’ll also ask what the coronavirus pandemic means to innovation, our community, and our relationship with society. They’ll discuss:

  • How synthetic biology has surpassed expectations, and the work that remains
  • What his experience tells him about his outlook on the coronavirus response
  • How coronavirus is shaping the public relationship with science
  • The most important trends of the next five years

Monday, April 6, 2020, 8 am Pacific

Click here to join our weekly newsletter. We want to hear what you think about this article. Got a tip for our news team? Write to editorial@synbiobeta.com.

Add comment

Job opportunities